43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 14
00:21 UTC
|
EAT
Brinker International
|
◎ Target | Jon Tower ★★★☆☆ #1651 | Buy | $227.00→ $282.00+24.2% |
|
Aug 14
00:21 UTC
|
DVN
Devon Energy
|
◎ Target | Hanwen Chang ★★★☆☆ #1933 | Overweight | $68.00→ $65.00-4.4% |
|
Aug 14
00:21 UTC
|
DPRO
Draganfly
|
◎ Target | Glenn Mattson not yet tracked | Buy | $12.75→ $11.50-9.8% |
|
Aug 14
00:21 UTC
|
DOCS
Doximity
|
◎ Target | Jailendra Singh ★★★☆☆ #1490 | Hold | $19.00→ $24.00+26.3% |
|
Aug 14
00:21 UTC
|
DOC
Healthpeak Properties
|
◎ Target | Amanda Sweitzer ★★☆☆☆ #2648 | Outperform | $21.00→ $24.00+14.3% |
|
Aug 14
00:21 UTC
|
DFTX
Definium Therapeutics
|
◎ Target | Christopher Chen not yet tracked | Outperform | $57.00→ $75.00+31.6% |
|
Aug 14
00:21 UTC
|
DFTX
Definium Therapeutics
|
◎ Target | Benjamin Burnett ★★☆☆☆ #2727 | Overweight | $68.00→ $72.00+5.9% |
|
Aug 14
00:21 UTC
|
DFTX
Definium Therapeutics
|
◎ Target | Brian Abrahams ★★☆☆☆ #2623 | Outperform | $57.00→ $66.00+15.8% |
|
Aug 14
00:21 UTC
|
DFTX
Definium Therapeutics
|
◎ Target | Justin Walsh ★★★☆☆ #1815 | Buy | $74.00→ $90.00+21.6% |
|
Aug 14
00:21 UTC
|
DCO
Ducommun
|
◎ Target | Michael Ciarmoli ★★★★☆ #521 | Buy | $150.00→ $209.00+39.3% |
|
Aug 14
00:21 UTC
|
D
Dominion Energy
|
◎ Target | Richard Sunderland ★★★☆☆ #1537 | Hold | $68.00→ $66.00-2.9% |
|
Aug 14
00:21 UTC
|
CYTK
Cytokinetics
|
◎ Target | Gena Wang ★★★★★ #86 | Overweight | $95.00→ $110.00+15.8% |
|
Aug 14
00:21 UTC
|
CYTK
Cytokinetics
|
◎ Target | Tessa Romero ★★★☆☆ #1178 | Overweight | $97.00→ $103.00+6.2% |
|
Aug 14
00:21 UTC
|
CTMX
CytomX Therapeutics
|
◎ Target | Anupam Rama ★★★☆☆ #1754 | Overweight | $12.00→ $11.00-8.3% |
|
Aug 14
00:21 UTC
|
CSU
Constellation Software
|
◎ Target | firm only | Outperform | C$4,500.00→ C$4,400.00-2.2% |
|
Aug 14
00:21 UTC
|
CSU
Constellation Software
|
◎ Target | firm only | C$3,185.00→ C$3,294.00+3.4% | |
|
Aug 14
00:21 UTC
|
CSU
Constellation Software
|
◎ Target | firm only | Outperform | C$3,500.00→ C$3,700.00+5.7% |
|
Aug 14
00:21 UTC
|
CSCO
Cisco Systems
|
◎ Target | Aaron Rakers ★★★☆☆ #2060 | Overweight | $130.00→ $150.00+15.4% |
|
Aug 14
00:21 UTC
|
CSCO
Cisco Systems
|
◎ Target | Matthew Niknam ★★★☆☆ #1840 | Buy | $125.00→ $140.00+12.0% |
|
Aug 14
00:21 UTC
|
CSCO
Cisco Systems
|
◎ Target | Tim Long ★★★☆☆ #2044 | Equal Weight | $121.00→ $123.00+1.7% |
|
Aug 14
00:21 UTC
|
CSCO
Cisco Systems
|
◎ Target | Brandon Nispel ★★★☆☆ #1276 | Overweight | $130.00→ $135.00+3.8% |
|
Aug 14
00:21 UTC
|
CSCO
Cisco Systems
|
◎ Target | Meta Marshall ★★★☆☆ #1577 | Overweight | $130.00→ $135.00+3.8% |
|
Aug 14
00:21 UTC
|
CSCO
Cisco Systems
|
◎ Target | Mike Genovese not yet tracked | Buy | $150.00→ $165.00+10.0% |
|
Aug 14
00:21 UTC
|
CSCO
Cisco Systems
|
◎ Target | David Vogt ★★★☆☆ #2165 | Buy | $132.00→ $138.00+4.5% |
|
Aug 14
00:21 UTC
|
CRWV
CoreWeave
|
◎ Target | Raimo Lenschow ★★★☆☆ #1626 | Equal Weight | $90.00→ $105.00+16.7% |
|
Aug 14
00:21 UTC
|
CRM
Salesforce
|
◎ Target | firm only | Buy | $200.00→ $222.00+11.0% |
|
Aug 14
00:21 UTC
|
CRGY
Crescent Energy
|
◎ Target | Hanwen Chang ★★★☆☆ #1933 | Overweight | $18.00→ $24.00+33.3% |
|
Aug 14
00:21 UTC
|
CPT
Camden Property Trust
|
◎ Target | Anthony Paolone ★★★★☆ #952 | Neutral | $113.00→ $114.00+0.9% |
|
Aug 14
00:21 UTC
|
COLD
Americold Realty Trust
|
◎ Target | Greg McGinniss ★★★☆☆ #1431 | Sec→ r Perform | $15.00→ $16.00+6.7% |
|
Aug 14
00:21 UTC
|
CM
Canadian Imperial Bank of Commerce
|
◎ Target | firm only | Sec→ r Perform | C$152.00→ C$180.00+18.4% |
|
Aug 14
00:21 UTC
|
CM
Canadian Imperial Bank of Commerce
|
◎ Target | firm only | Hold | C$143.00→ C$153.00+7.0% |
|
Aug 14
00:21 UTC
|
CIB
Grupo Cibest
|
◎ Target | Tito Labarta ★★★☆☆ #1020 | Buy | $98.00→ $110.00+12.2% |
|
Aug 14
00:21 UTC
|
CHRD
Chord Energy
|
◎ Target | Hanwen Chang ★★★☆☆ #1933 | Overweight | $175.00→ $163.00-6.9% |
|
Aug 14
00:21 UTC
|
CGEM
Cullinan Therapeutics
|
◎ Target | Robert Driscoll ★★★☆☆ #998 | Outperform | $39.00→ $42.00+7.7% |
|
Aug 14
00:21 UTC
|
CCOI
Cogent Communications
|
◎ Target | Michael Rollins ★★★☆☆ #1849 | Neutral | $20.00→ $11.50-42.5% |
|
Aug 14
00:21 UTC
|
CCOI
Cogent Communications
|
◎ Target | Jonathan Atkin ★★★☆☆ #1587 | Sec→ r Perform | $18.00→ $12.00-33.3% |
|
Aug 14
00:21 UTC
|
CC
Chemours
|
◎ Target | Jeffrey Zekauskas ★★★★☆ #500 | Neutral | $22.00→ $15.00-31.8% |
|
Aug 14
00:21 UTC
|
CC
Chemours
|
◎ Target | John McNulty ★★★☆☆ #2147 | Outperform | $26.00→ $18.00-30.8% |
|
Aug 14
00:21 UTC
|
CBRS
Cerebras Systems
|
◎ Target | Matt Bryson ★★★☆☆ #2002 | Outperform | $280.00→ $290.00+3.6% |
|
Aug 14
00:21 UTC
|
CBRS
Cerebras Systems
|
◎ Target | Vijay Rakesh ★★☆☆☆ #2724 | Outperform | $310.00→ $300.00-3.2% |
|
Aug 14
00:21 UTC
|
CBRS
Cerebras Systems
|
◎ Target | Atif Malik ★★★☆☆ #2012 | Buy | $340.00→ $320.00-5.9% |
|
Aug 14
00:21 UTC
|
CBRS
Cerebras Systems
|
◎ Target | Timothy Arcuri ★★☆☆☆ #2458 | Buy | $320.00→ $330.00+3.1% |
|
Aug 14
00:21 UTC
|
CBRS
Cerebras Systems
|
◎ Target | Joseph Moore ★★★☆☆ #2142 | Overweight | $273.00→ $279.00+2.2% |
|
Aug 14
00:21 UTC
|
CAVA
CAVA Group
|
◎ Target | Gregory Francfort ★★★★☆ #667 | Buy | $100.00→ $95.00-5.0% |
|
Aug 14
00:21 UTC
|
CAVA
CAVA Group
|
◎ Target | Matt Curtis ★★★☆☆ #1383 | Neutral | $84.00→ $75.00-10.7% |
|
Aug 14
00:21 UTC
|
CAH
Cardinal Health
|
◎ Target | Charles Rhyee ★★★☆☆ #1267 | Buy | $275.00→ $280.00+1.8% |
|
Aug 14
00:21 UTC
|
CAH
Cardinal Health
|
◎ Target | Lisa Gill ★★★★☆ #593 | Neutral | $215.00→ $260.00+20.9% |
|
Aug 14
00:21 UTC
|
CAH
Cardinal Health
|
◎ Target | Glen Santangelo ★★★☆☆ #1449 | Overweight | $258.00→ $275.00+6.6% |
|
Aug 14
00:21 UTC
|
BYD
Boyd Group Services
|
◎ Target | firm only | Sec→ r Outperform | C$219.00→ C$210.00-4.1% |
|
Aug 14
00:21 UTC
|
BYD
Boyd Group Services
|
◎ Target | firm only | Outperform | C$245.00→ C$236.00-3.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.